Gawęcki Maciej, Prądzyńska Natalia, Kiciński Krzysztof, Ratajczak Agnieszka, Karska-Basta Izabella, Grzybowski Andrzej
Department of Ophthalmology of Specialist Hospital in Chojnice, Lesna, Chojnice, Poland.
Dobry Wzrok Ophthalmological Clinic, Zabi Kruk, Gdańsk, Poland.
Adv Ophthalmol Pract Res. 2023 Mar 5;3(2):86-92. doi: 10.1016/j.aopr.2023.02.003. eCollection 2023 May-Jun.
Enhanced depth-of- focus intraocular lenses (EDOF IOL) have filled the gap between monofocal and multifocal intraocular implants with optical qualities of monofocal lenses and usually minor dysphotopsias typical for multifocal lenses. The purpose of this study was to evaluate visual outcomes after bilateral implantation of a new EDOF IOL in patients with requirements for perfect near and intermediate vision.
The study included 15 patients (29 eyes as one was amblyopic) with bilateral implantation of LUXSMART EDOF IOL (Bausch & Lomb) with a targeted myopia (between -0.25 and -0.50D) in both eyes. Monocular corrected and uncorrected visual acuity for far, intermediate and near as well as refractive outcomes were evaluated at 1, 3, 6 and 12 months after the surgery. Additionally, binocular visual acuity, contrast sensitivity and defocus curve were measured at the final follow-up visit. At 12 months' visit patients completed a questionnaire evaluating patient satisfaction, spectacle independence and presence of dysphotopsias.
Binocular uncorrected visual acuities at 12 month's visit were 0.13 ± 0.16, 0.06 ± 0.08, 0.07 ± 0.09 and 0.15 ± 0.09 logMAR for far distance, 80 cm, 66 cm and 40 cm respectively. Corrected binocular visual acuities at 12 months were 0.00 ± 0.00, 0.05 ± 0.07, 0.05 ± 0.06, 0.13 ± 0.16 respectively for distance, 80 cm, 66 cm and 40 cm. Automated refraction spherical equivalent at 12 months' visit stood at -0.70 ± 0.48D, which was 0.46D less than calculated biometric target, however spherical equivalent of subjective refraction at 12 months equaled -0.49 ± 0.46D, which was closer to preoperative biometric target. Defocus curve had gentle shape without peaks typical for monofocal IOLs. Binocular contrast sensitivity results were superior to average results for that age group and equaled 1.78 ± 0.16 logMAR without correction and 1.81 ± 0.13 logMAR with correction. Spectacle independence for near and intermediate distances was achieved in all patients and for far distance in 73.3% of patients. Burdensome dysphotopsias were not reported in any case.
EDOF IOLs targeted bilaterally at low myopia can provide excellent near and intermediate visual acuity and independence of any optical correction in majority of cases. This approach can be used in selected patients who are focused on stationary activities.
增强景深人工晶状体(EDOF IOL)填补了单焦点和多焦点人工晶状体之间的空白,兼具单焦点晶状体的光学质量,且通常具有多焦点晶状体典型的轻微眩光。本研究的目的是评估在有完美近视力和中视力需求的患者中双侧植入新型EDOF IOL后的视觉效果。
本研究纳入15例患者(29只眼,其中1例为弱视),双眼植入LUXSMART EDOF IOL(博士伦公司),双眼目标近视度数在-0.25至-0.50D之间。在术后1、3、6和12个月评估远、中、近视力的单眼矫正和未矫正视力以及屈光结果。此外,在最后一次随访时测量双眼视力、对比敏感度和散焦曲线。在12个月随访时,患者完成一份问卷,评估患者满意度、无需眼镜情况和眩光情况。
12个月随访时,远距离、80cm、66cm和40cm的双眼未矫正视力分别为0.13±0.16、0.06±0.08、0.07±0.09和0.15±0.09 logMAR。12个月时远距离、80cm、66cm和40cm的双眼矫正视力分别为0.00±0.00、0.05±0.07、0.05±0.06和0.13±0.16。12个月随访时自动验光等效球镜度数为-0.70±0.48D,比计算的生物测量目标低0.46D,然而12个月时主观验光等效球镜度数为-0.49±0.46D,更接近术前生物测量目标。散焦曲线形状平缓,没有单焦点IOL典型的峰值。双眼对比敏感度结果优于该年龄组的平均结果,未矫正时为1.78±0.16 logMAR,矫正后为1.81±0.13 logMAR。所有患者在近距和中距实现了无需眼镜,73.3%的患者在远距实现了无需眼镜。在任何情况下均未报告严重眩光。
双侧针对低度近视的EDOF IOL在大多数情况下可提供出色的近视力和中视力,且无需任何光学矫正。这种方法可用于专注于静态活动的特定患者。